| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Kristal Robert Eugene is a Chief Financial Officer at BRTX. Recent filings cover 3 purchases and 0 sales. Those positions are worth an estimated $2K at current prices.
Our model assigns Kristal Robert Eugene a below-average insider score of 38/100, based on 3 past trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of +11.4%.
Kristal Robert Eugene's largest disclosed position is in BRTX as Chief Financial Officer, worth about $2K. Net of sales, the recent Form 4 record there shows accumulation of 7,994 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2022 | BRTX Biorestorative Therapies, Inc. | Chief Financial Officer | Buy | 194 | $3.61 | $700.34 | +2.5% | -13.9% | +55.7% | |
| Jun 7, 2022 | BRTX Biorestorative Therapies, Inc. | Chief Financial Officer | Buy | 200 | $4.56 | $912.00 | +2.6% | -31.1% | +15.2% | |
| Apr 8, 2022 | BRTX Biorestorative Therapies, Inc. | Chief Financial Officer | Buy | 7,600 | $5.71 | $43,396.00 | New | -39.3% | -36.8% |